ALHYG — Hybrigenics SA Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- €14.29m
- €13.83m
Annual income statement for Hybrigenics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.077 | 0.235 | -0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0.046 | 0.234 | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7.38 | 7.76 | 0.86 | 0.362 | 0.489 |
| Operating Profit | -7.38 | -7.69 | -0.625 | -0.363 | -0.489 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.29 | -7.88 | -0.796 | -0.327 | -0.069 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.29 | -7.53 | -0.736 | -0.327 | -0.069 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -7.96 | -7.53 | -0.736 | -0.327 | -0.069 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.96 | -7.53 | -0.736 | -0.327 | -0.069 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.156 | -0.16 | -0.005 | -0.001 | 0.001 |
| Dividends per Share |